ClinicalTrials.Veeva

Menu

Penetration and Compartimentation of HIV

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

HIV

Treatments

Other: sample

Study type

Observational

Funder types

Other

Identifiers

NCT02513758
0201078
DGS 2002/0521 (Other Identifier)

Details and patient eligibility

About

Genital mucosa is the main way of HIV penetration. Many cells can be involved (epithelial cells, Langerhans cells) and antibodies may also play a critical role. The investigators' study aims to precise the role of each type of cells, the interaction cell-cell and cell-antibodies.

Full description

At inclusion, men will have a two blood sampling tubes of 10 ml each, a saliva sample and a sample of sperm and women will have a two blood sampling tubes of 10 ml each, a saliva sample and a sampling cervicovaginal secretions

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (> 18 year-old) HIV positive,
  • HIV-CV> 1000 cp/ml,

Exclusion criteria

  • children

Trial design

200 participants in 1 patient group

HIV patients
Description:
Men will have blood sampling tubes of 10 ml each, a saliva sample and a sample of sperm Women will have a two blood sampling tubes of 10 ml each, a saliva sample and a sampling cervicovaginal secretions
Treatment:
Other: sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems